Interpace Biosciences (IDXG) Short Interest Ratio & Short Volume → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free IDXG Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisCompetitorsEarningsHeadlinesSocial MediaStock AnalysisCompetitorsEarningsHeadlinesSocial Media Interpace Biosciences Short Interest DataCurrent Short Volume47,400 sharesPrevious Short Volume29,800 sharesChange Vs. Previous Month+59.06%Dollar Volume Sold Short$265,914.00Short Interest Ratio / Days to Cover0.2Last Record DateFebruary 12, 2021Outstanding Shares4,370,000 sharesFloat Size3,780,000 sharesShort Percent of Float1.25%Today's Trading Volume5 sharesAverage Trading Volume5,577 sharesToday's Volume Vs. Average0% Short Selling Interpace Biosciences ? Sign up to receive the latest short interest report for Interpace Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIDXG Short Interest Over TimeIDXG Days to Cover Over TimeIDXG Percentage of Float Shorted Over Time Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! Interpace Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/12/202147,400 shares $265,914.00 +59.1%1.3%0.2 $5.61 1/29/202129,800 shares $126,352.00 -56.6%0.8%0.2 $4.24 1/15/202168,600 shares $276,458.00 -44.2%1.8%0.5 $4.03 12/31/2020123,000 shares $403,440.00 +21.1%3.3%0.1 $3.28 12/15/2020101,600 shares $327,152.00 -18.9%2.7%0.1 $3.22 11/30/2020125,300 shares $415,244.20 -18.9%3.3%0.1 $3.31 Get the Latest News and Ratings for IDXG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Interpace Biosciences and its competitors with MarketBeat's FREE daily newsletter. 11/15/2020154,400 shares $478,640.00 -31.6%3.9%0.2 $3.10 10/30/2020225,700 shares $778,665.00 -6.7%5.6%0.2 $3.45 10/15/2020241,800 shares $957,528.00 -3.0%6.1%0.2 $3.96 9/30/2020249,200 shares $770,028.00 -21.9%6.2%0.8 $3.09 9/15/2020319,000 shares $1.08 million +28.0%8.0%0.7 $3.37 8/31/2020249,200 shares $872,200.00 +7.0%6.2%0.5 $3.50 8/14/2020233,000 shares $1.35 million +11.5%5.8%0.5 $5.78 7/31/2020208,900 shares $1.23 million +13.0%5.7%0.6 $5.87 7/15/2020184,900 shares $870,879.00 +57.9%4.6%0.5 $4.71 6/30/2020117,100 shares $562,080.00 +20.6%2.9%0.5 $4.80 6/15/202097,100 shares $504,920.00 -2.0%2.4%1.2 $5.20 5/29/202099,100 shares $504,419.00 -18.6%2.5%1.2 $5.09 5/15/2020121,700 shares $571,990.00 -3.3%3.0%1.6 $4.70 4/30/2020125,800 shares $699,448.00 -6.7%3.1%1.9 $5.56 4/15/2020134,800 shares $648,388.00 -9.1%3.4%2.1 $4.81 3/31/2020148,300 shares $768,194.00 -1.8%3.9%2.1 $5.18 3/13/2020151,000 shares $978,480.00 +2.4%4.0%2.6 $6.48 2/28/2020147,400 shares $1.21 million +7.3%3.9%2.2 $8.22 2/14/2020137,400 shares $1.21 million +7.2%3.6%2.1 $8.80 1/31/2020128,200 shares $1.16 million -6.9%3.4%2.1 $9.08 1/15/2020137,700 shares $1.15 million -90.8%4.3%2.7 $8.37 12/31/20191,500,000 shares $11.10 million +36.4%4.0%45.2 $7.40 IDXG Short Interest - Frequently Asked Questions What is Interpace Biosciences' current short interest? Short interest is the volume of Interpace Biosciences shares that have been sold short but have not yet been covered or closed out. As of February 12th, investors have sold 47,400 shares of IDXG short. 1.25% of Interpace Biosciences' shares are currently sold short. Learn More on Interpace Biosciences' current short interest. What is a good short interest percentage for Interpace Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.25% of Interpace Biosciences' floating shares are currently sold short. Is Interpace Biosciences' short interest increasing or decreasing? Interpace Biosciences saw a increase in short interest in February. As of February 12th, there was short interest totaling 47,400 shares, an increase of 59.1% from the previous total of 29,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Interpace Biosciences' float size? Interpace Biosciences currently has issued a total of 4,370,000 shares. Some of Interpace Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Interpace Biosciences currently has a public float of 3,780,000 shares. How does Interpace Biosciences' short interest compare to its competitors? 1.25% of Interpace Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Interpace Biosciences: NeuroMetrix, Inc. (0.81%), Avinger, Inc. (3.64%), Vivos Therapeutics, Inc. (0.81%), Plus Therapeutics, Inc. (1.11%), Venus Concept Inc. (0.72%), Minerva Surgical, Inc. (92.12%), Acutus Medical, Inc. (4.46%), Sharps Technology, Inc. (1.61%), Assure Holdings Corp. (4.29%), Aethlon Medical, Inc. (0.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($5.62 billion), Charter Communications, Inc. ($5.35 billion), Analog Devices, Inc. ($5.07 billion), Snap Inc. ($3.60 billion), Futu Holdings Limited ($2.92 billion), Palantir Technologies Inc. ($2.55 billion), Airbnb, Inc. ($2.52 billion), Snowflake Inc. ($2.38 billion), Peloton Interactive, Inc. ($2.22 billion), and The Kroger Co. ($2.07 billion). View all of the most shorted stocks. What does it mean to sell short Interpace Biosciences stock? Short selling IDXG is an investing strategy that aims to generate trading profit from Interpace Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Interpace Biosciences? A short squeeze for Interpace Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IDXG, which in turn drives the price of the stock up even further. How often is Interpace Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IDXG, twice per month. The most recent reporting period available is February, 12 2021. More Short Interest Resources from MarketBeat Related Companies: NeuroMetrix Short Squeeze Avinger Short Squeeze Vivos Therapeutics Short Squeeze Plus Therapeutics Short Squeeze Venus Concept Short Squeeze Minerva Surgical Short Squeeze Acutus Medical Short Squeeze Sharps Technology Short Squeeze Assure Short Squeeze Aethlon Medical Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IDXG) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden’s $374B Giveaway Into This SectorDTIThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsMy biggest AI fearParadigm Press